Clinical Trials Browser

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT00813878 2017-10-13

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Terminated

126 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT00788112 2017-08-07

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Phase 1 Completed

17 enrolled

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Completed

28 enrolled 13 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00363012 2017-04-05

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Phase NA Completed

56 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00379509 2017-03-21

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer

Phase 1 Completed

20 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00896857 2017-03-15

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

Completed

30 enrolled

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003854 2016-07-13

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Phase 3 Completed

4,590 enrolled

Breast

Breast Neoplasms

NCT00898976 2016-07-13

Biomarkers in Native American Women With Breast Cancer

Completed

120 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00664781 2016-05-24

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Phase 2 Completed

78 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Completed

98 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00897338 2015-10-12

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Completed

43 enrolled

Breast

Breast Neoplasms

NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Withdrawn

Breast

Breast Neoplasms

NCT02353988 2015-02-03

Arbre

Phase 2 Unknown

60 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00918216 2014-07-16

Spectroscopy of Breast Tissue

Completed

141 enrolled

Breast

Breast Neoplasms

NCT01292083 2014-02-06

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00918788 2013-08-22

Laser Spectroscopy of Breast Tissue Through a Needle Device

Completed

17 enrolled

Breast

Breast Neoplasms

NCT00369109 2013-04-08

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Completed

60 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00429988 2012-09-26

Study of Ductal Lavage in Women at High Risk for Breast Cancer

Completed

30 enrolled

Breast

Breast Neoplasms

NCT00633750 2012-09-05

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Phase 2 Completed

50 enrolled 9 charts

Breast

Breast Neoplasms

NCT00611715 2012-08-09

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.

Phase 2 Terminated

48 enrolled 11 charts

Breast

Breast Neoplasms

NCT00900094 2012-02-07

IRB 2000-294

Completed

200 enrolled

BreastGastrointestinalGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Ovarian Epithelial, Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00361049 2010-11-05

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Phase 1 Completed

49 enrolled

BreastGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Clinical Trials

LDTam

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Fibrotic Focus in Breast Cancer

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease

Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Biomarkers in Native American Women With Breast Cancer

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Lapatinib Resistance in Patients With Breast Cancer

Arbre

Spectroscopy of Breast Tissue

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Laser Spectroscopy of Breast Tissue Through a Needle Device

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Study of Ductal Lavage in Women at High Risk for Breast Cancer

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.

IRB 2000-294

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant